Target Name: KRTAP5-2
NCBI ID: G440021
Review Report on KRTAP5-2 Target / Biomarker Content of Review Report on KRTAP5-2 Target / Biomarker
KRTAP5-2
Other Name(s): Ultrahigh sulfur keratin-associated protein 5.2 | KAP5.2 | Keratin associated protein 5-2 | Keratin-associated protein 5.8 | Keratin-associated protein 5.2 | Keratin-associated protein 5-8 | KRTAP5.8 | KRTAP5-8 | keratin-associated protein 5.8 | KAP5-8 | keratin-associated protein 5-2 | keratin-associated protein 5.2 | keratin associated protein 5-2 | keratin-associated protein 5-8 | Keratin-associated protein 5-2 | ultrahigh sulfur keratin-associated protein 5.2 | KRTAP5.2 | KRA52_HUMAN

Unlocking the Potential of KRTAP5-2: A Promising Drug Target and Biomarker

Introduction

KRTAP5-2, also known as Ultrahigh sulfur keratin-associated protein 5.2, is a gene that encodes a protein located in the major basic tissue phase (MBI) alpha-helical domain. This protein has multiple functions in organisms, such as participating in cell signaling, cell adhesion, cell proliferation and differentiation, etc. In recent years, scientists have discovered that KRTAP5-2 has a significant precancerous role in certain diseases, such as skin cancer, liver cancer, breast cancer, and kidney cancer. In addition, studies have also shown that KRTAP5-2 is positively correlated with the onset of various cancers. Therefore, KRTAP5-2 is considered a potential drug target and biomarker.

Structure and function of KRTAP5-2

KRTAP5-2 is a polypeptide with a length of 294 amino acids and a molecular weight of 31 kDa. The protein consists of two domains: the N-terminal 浼?-helical domain and the C-terminal 灏?-sheet domain. The N-terminal 浼?-helical domain includes 12 浼?-helices, while the C-terminal 灏?-sheet domain includes 22 灏?-sheets. In addition, the C-terminus of KRTAP5-2 contains a highly conserved cysteine 閳ュ??濯焑sidue, which can undergo oxidative modification and thereby participate in the stability and function of KRTAP5-2.

The role of KRTAP5-2 in cell signaling

KRTAP5-2 plays multiple roles in cell signaling. First, KRTAP5-2 can interact with a variety of proteins, such as FAK, PD-L1, and CTLA-4. These interactions contribute to KRTAP5-2's critical role in signal transduction pathways. Secondly, KRTAP5-2 can regulate cell cycle and promote cell proliferation and differentiation. In addition, KRTAP5-2 can also participate in processes such as cell adhesion, cell migration and apoptosis.

The role of KRTAP5-2 in tumorigenesis

Studies have found that KRTAP5-2 has a significant precancerous role in a variety of cancers. For example, KRTAP5-2 is positively correlated with the occurrence of tumors such as skin cancer, liver cancer, breast cancer, and kidney cancer. In addition, the expression level of KRTAP5-2 was positively correlated with tumor invasiveness and metastasis. Therefore, KRTAP5-2 is considered an important biomarker in tumorigenesis.

Pharmacological significance of KRTAP5-2

Because KRTAP5-2 has a significant precancerous role in a variety of cancers, it is considered a potential drug target. Currently, some studies are exploring the efficacy of KRTAP5-2 as an anti-tumor drug. For example, some studies have demonstrated good synergy between KRTAP5-2 and anti-tumor drugs such as cisplatin, carboplatin, and paclitaxel. In addition, some studies have also found that antagonists of KRTAP5-2, such as PD-L1 inhibitors and CTLA-4 inhibitors, have significant anti-tumor effects.

Biological significance of KRTAP5-2

KRTAP5-2 has multiple functions in biology. First, KRTAP5-2 can participate in cell signaling, regulate cell cycle, and promote cell proliferation and differentiation. Secondly, KRTAP5-2 can participate in processes such as cell adhesion, cell migration and apoptosis. In addition, KRTAP5-2 can also interact with other proteins, such as FAK, PD-L1 and CTLA-4, thus playing a key role in signal transduction pathways.

Conclusion

KRTAP5-2 is an important protein with multiple functions in organisms. Through its role in cell signaling, cell adhesion, cell migration and cell apoptosis, KRTAP5-2 has been shown to be a potential drug target and biomarker in various diseases, including cancer. Further research is needed to fully understand the biology and pharmacology of KRTAP5 -2, and to explore its potential as a therapeutic agent.

Protein Name: Keratin Associated Protein 5-2

Functions: In the hair cortex, hair keratin intermediate filaments are embedded in an interfilamentous matrix, consisting of hair keratin-associated protein (KRTAP), which are essential for the formation of a rigid and resistant hair shaft through their extensive disulfide bond cross-linking with abundant cysteine residues of hair keratins. The matrix proteins include the high-sulfur and high-glycine-tyrosine keratins

The "KRTAP5-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KRTAP5-2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

KRTAP5-3 | KRTAP5-4 | KRTAP5-5 | KRTAP5-7 | KRTAP5-8 | KRTAP5-9 | KRTAP5-AS1 | KRTAP6-1 | KRTAP6-2 | KRTAP6-3 | KRTAP7-1 | KRTAP8-1 | KRTAP9-1 | KRTAP9-2 | KRTAP9-3 | KRTAP9-4 | KRTAP9-6 | KRTAP9-7 | KRTAP9-8 | KRTAP9-9 | KRTCAP2 | KRTCAP3 | KRTDAP | KSR1 | KSR1P1 | KSR2 | KTI12 | KTN1 | KTN1-AS1 | KXD1 | KY | KYAT1 | KYAT3 | KYNU | L-Type calcium channel | L-type voltage-dependent calcium channel complex | L1CAM | L1CAM-AS1 | L1TD1 | L2HGDH | L3HYPDH | L3MBTL1 | L3MBTL2 | L3MBTL3 | L3MBTL4 | L3MBTL4-AS1 | LACAT1 | LACC1 | LACRT | Lactate Dehydrogenase (LDH) | LACTB | LACTB2 | LACTB2-AS1 | LACTBL1 | LAD1 | LAG3 | LAGE3 | LAIR1 | LAIR2 | LALBA | LAMA1 | LAMA2 | LAMA3 | LAMA4 | LAMA5 | LAMB1 | LAMB2 | LAMB2P1 | LAMB3 | LAMB4 | LAMC1 | LAMC1-AS1 | LAMC2 | LAMC3 | Laminin-5 | Laminins | LAMP1 | LAMP2 | LAMP3 | LAMP5 | LAMP5-AS1 | LAMTOR1 | LAMTOR2 | LAMTOR3 | LAMTOR3P1 | LAMTOR4 | LAMTOR5 | LAMTOR5-AS1 | LanC-like proteins | LANCL1 | LANCL1-AS1 | LANCL2 | LANCL3 | LAP3 | LAP3P2 | LAPTM4A | LAPTM4B | LAPTM4BP2 | LAPTM5 | Large Conductance BK(Ca) Potassium Channel (Maxi K+ Channel)